Reuters logo
BRIEF-Incyte and Agenus amend collaboration agreement
February 14, 2017 / 12:17 PM / in 9 months

BRIEF-Incyte and Agenus amend collaboration agreement

Feb 14 (Reuters) - Incyte Corp :

* Incyte and Agenus amend collaboration agreement

* Says Agenus to receive $80 million from Incyte

* Incyte Corp - amended agreement converts ongoing GITR and ox40 antibody programs from co-funded development and profit-sharing arrangements to royalty-bearing programs

* Agenus would now become eligible to receive 15 percent royalties on global net sales of each approved product

* Incyte Corp - parties also entered into separate stock purchase agreement whereby Incyte will purchase 10 million shares of Agenus common stock today at $6 per share

* Says ongoing tim-3 and lag-3 antibody programs remain royalty-bearing programs, at tiered rates of 6 to 12 percent Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below